Hepatitis C prevalence in England remains low and varies by ethnicity: an updated evidence synthesis.
about
Hepatitis C - Assessment to Treatment Trial (HepCATT) in primary care: study protocol for a cluster randomised controlled trial.Cost-effectiveness of HCV case-finding for people who inject drugs via dried blood spot testing in specialist addiction services and prisonsPrevalence and estimation of hepatitis B and C infections in the WHO European Region: a review of data focusing on the countries outside the European Union and the European Free Trade Association.Bridging the data gaps in the epidemiology of hepatitis C virus infection in Malaysia using multi-parameter evidence synthesisHepatitis C in men who have sex with men in London--a community surveyHepatitis C virus in the new era: perspectives in epidemiology, prevention, diagnostics and predictors of response to therapy.Modelling the impact of improving screening and treatment of chronic hepatitis C virus infection on future hepatocellular carcinoma rates and liver-related mortality.Using surveillance data to determine treatment rates and outcomes for patients with chronic hepatitis C virus infection.Illness perceptions and explanatory models of viral hepatitis B & C among immigrants and refugees: a narrative systematic review.The prevalence of hepatitis C virus infection and its related risk factors among the rural population of fars province, southern iran.HCV treatment rates and sustained viral response among people who inject drugs in seven UK sites: real world results and modelling of treatment impact.Hepatitis C virus treatment as prevention in people who inject drugs: testing the evidence.Hepatitis C virus seroprevalence in pregnant women delivering live-born infants in North Thames, England in 2012.Estimating the number of people with hepatitis C virus who have ever injected drugs and have yet to be diagnosed: an evidence synthesis approach for Scotland.Is increased hepatitis C virus case-finding combined with current or 8-week to 12-week direct-acting antiviral therapy cost-effective in UK prisons? A prevention benefit analysisNew treatments for hepatitis C virus (HCV): scope for preventing liver disease and HCV transmission in EnglandCase-finding for hepatitis C in primary care: a mixed-methods service evaluation.Treatment of chronic viral hepatitis C in children and adolescents: UK experience.Historical epidemiology of hepatitis C virus (HCV) in selected countries.Intervention to improve management of acute hepatitis C infection in a UK sexual health clinic.Finding the undiagnosed: a qualitative exploration of hepatitis C diagnosis delay in the United Kingdom.Healthcare seeking and hospital admissions by people who inject drugs in response to symptoms of injection site infections or injuries in three urban areas of England.Ethnic Variations in Liver- and Alcohol-Related Disease Hospitalisations and Mortality: The Scottish Health and Ethnicity Linkage Study.Prevention of progression to cirrhosis in hepatitis C with fibrosis: effectiveness and cost effectiveness of sequential therapy with new direct-acting anti-virals.Economic evaluation of ombitasvir/paritaprevir/ritonavir and dasabuvir for the treatment of chronic genotype 1 hepatitis c virus infection.Is universal screening for hepatitis C infection prior to commencing antitumour necrosis factor-α therapy necessary?The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence.Low incidence of hepatitis C virus among prisoners in Scotland.Assessing the cost utility of response-guided therapy in patients with chronic hepatitis C genotype 1 in the UK using the MONARCH model.Developing a community HCV service: project ITTREAT (integrated community-based test - stage - TREAT) service for people who inject drugs.Detecting Hepatitis B and C by Combined Public Health and Primary Care Birth Cohort Testing.Use of injected heroin and risk of hepatitis C in three cities in Colombia.Multiple parameter evidence synthesis--a potential solution for when information on drug use and harm is in conflict.Impact of current and scaled-up levels of hepatitis C prevention and treatment interventions for people who inject drugs in three UK settings-what is required to achieve the WHO's HCV elimination targets?
P2860
Q27332215-331C6D29-9A89-4B05-AA1C-9EA2559F1191Q28681550-DA404A36-DE4B-4632-A7B1-27AED9527FF6Q30634658-A850CED4-1701-427C-8355-8BD85560DC1AQ30868237-CA511968-DBC4-4242-9E50-627999EB79CDQ33593593-7B44DF01-04CF-46C2-B904-C8D1480B1536Q34008754-9DCE3583-31F5-458D-B0A5-9224FEC49593Q34028307-969AA299-E9B3-4771-90B8-8779113389DCQ34643724-22882DB6-66DF-416C-B079-C8FAD0087937Q35108552-5FD39A8E-7B0E-4918-BA71-66758254A705Q35149320-281F87D8-9868-4569-B0DF-75793A5B1E7BQ35535844-20693B64-42D7-4025-9961-27B177CA59F4Q36319803-FB3B12B2-A455-40BD-9BFB-9EE76394F8E6Q36466354-EAB7BDFA-7782-4714-B436-DA82E409460FQ36554358-C62D8CE7-C470-4FC6-80F0-809F4E1CF14EQ37035896-5811BA3A-9D70-47C6-AFDF-30095D41A3DBQ37169457-EF3B5D89-F08B-47A7-B97C-55A062F33C16Q37527057-AFD51E62-36CD-49CE-AA4D-E3949AE6C592Q38184887-CD476066-8E74-48B4-AA51-46E6A87EF149Q38203033-80C5E799-0165-4767-8FE1-5EC8944F9A0DQ38611388-C3DB9AE9-F9B7-469A-AAF6-FAE936B0ED7CQ38902293-40A274EB-95C1-462E-96B5-34B791A888DEQ39076643-246601BA-EFDB-413B-B33C-5E389B9B3FC0Q39786796-0C51A1ED-E0CC-4F90-9453-469C2BC1F9FCQ40562865-94B0F0F8-5E9E-43D2-BBFD-272C05072F76Q40677384-A8C97468-502A-4E75-8D9E-66FCF8742D0CQ42270023-4535D54A-D5C3-438F-A2CC-8A5EB6980FF0Q42602432-C10681AD-B335-4A27-B82A-2F058F20EBCCQ42987991-2F03EED0-4562-4E63-BDB5-151C6639E57CQ42988428-92654179-16DD-4B10-9553-24393A10180EQ47376607-8B54737D-1B58-48C3-8551-F8163B3EA67DQ47557121-F0A42E82-1DE5-4937-9B82-73388EB8C330Q47574660-5D61C980-B516-499C-9A2E-8334C7A4A63EQ52302553-58126B50-39F0-4EE9-8331-1C344B6C411FQ57700826-BDAE8DE3-1858-4AC1-970E-DE3503CE67E5
P2860
Hepatitis C prevalence in England remains low and varies by ethnicity: an updated evidence synthesis.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Hepatitis C prevalence in Engl ...... an updated evidence synthesis.
@en
Hepatitis C prevalence in Engl ...... an updated evidence synthesis.
@nl
type
label
Hepatitis C prevalence in Engl ...... an updated evidence synthesis.
@en
Hepatitis C prevalence in Engl ...... an updated evidence synthesis.
@nl
prefLabel
Hepatitis C prevalence in Engl ...... an updated evidence synthesis.
@en
Hepatitis C prevalence in Engl ...... an updated evidence synthesis.
@nl
P2093
P2860
P356
P1476
Hepatitis C prevalence in Engl ...... an updated evidence synthesis.
@en
P2093
Daniela De Angelis
Graham R Foster
Lisa Brant
Mary Ramsay
Ross J Harris
P2860
P304
P356
10.1093/EURPUB/CKR083
P407
P577
2011-06-26T00:00:00Z